Company news
Rafael Holdings, Inc. (NYSE:RFL) news
Every Rafael Holdings, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
June 11, 2026
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for t...
June 10, 2026
Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s D...
April 22, 2026
Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results
March 16, 2026
Rafael : Quarterly Report for Quarter Ending October 31, 2025 (Form 10-Q)
December 12, 2025
Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results
December 11, 2025
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
October 29, 2025
Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its ...
October 28, 2025
Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label, Single-Arm Sub-Study in Patient...
September 16, 2025
Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Met...
August 27, 2025
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independen...
June 18, 2025
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
June 11, 2025
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
June 4, 2025
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Pre...
May 20, 2025
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Su...
May 5, 2025
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potentia...
April 29, 2025
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be ...
April 24, 2025
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
March 26, 2025
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results
March 13, 2025
Rafael : Amendment to Annual Report (Form 10-K/A)
December 20, 2024
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
December 11, 2024
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
November 6, 2024